Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

How much more demand can silver handle?

The numbers for silver demand are starting to make some market-watchers nervous. The U.S. Mint sold over 6.4 million silver Eagles in January, more than any other month since the coin’s introduction in 1986. China’s net imports of silver quadr...
Jeff Clark, Casey Research | October 28, 2012 |

Is the party over for stocks?

With the precipitous tail end of 2008’s crash extending into March 2009 (and the relentless rise over the rest of the year), it hasn’t even remotely resembled a “normal” year for stocks. Rising from the depths of gloom ...
Nick Thomas | October 28, 2012 |

The Right Tools at the Right Time to Control Crop Disease & Boost Yields

Download the episode here . Agri-tech Company Bee Vectoring Technologies International Inc. ( TSX-V: BEE , OTCQB: BEVVF , Forum ) has pioneered a unique and natural precision agriculture system that uses commercially-grown bees to deliver biological crop ...
Stockhouse Media | July 16, 2020 |

Novamind’s Trial Site for Merck Another Example Of Its Leadership in Mental Health

Novamind’s clinics and clinical research capabilities are already well established to bring alternative mental health therapies, including psychedelic medicine, to market. One of the world’s largest pharmaceutical companies has selected ...
Featured Submission | March 24, 2021 |

Novamind Selected by Merck to Advance Research for Treatment-Resistant Depression

Novamind’s subsidiary, Cedar Clinical Research, to serve as a key clinical research site Independent validation of the expertise and capabilities of Novamind in managing clinical trials Adds to established track record conducting research a...
Featured Submission | March 18, 2021 |

Increased Cannabis Interest Paves Way for Cannabinoid Production

As the cannabis market has started to recover amidst the COVID-19 pandemic, investors are looking at where the market can grow. One leading candidate is cannabinoid production. THC, CBD, and other specific cannabinoids can be useful for a variety of treatments, includ...
Omri Wallach | June 9, 2020 |

From COVID to Nicotine Treatments, this Bio Stock is One to Watch

(Image via Lexaria Bioscience Corp.) There’s no shortage of excitement over potential COVID-19 vaccines. Just looking at the response to news around these developments is evidence of that, and one Company is working on a transformative, patented tech...
Stockhouse Editorial | December 1, 2020 |

Viela Bio Shares Trade Higher After Analyst Issues 'Buy' Recommendation

Shares of Viela Bio Inc. rose 20% after an analyst at H.C. Wainwright & Co. initiated coverage of the stock. This morning, shares of clinical-stage biotechnology firm Viela Bio Inc. (VIE:NASDAQ) , which is focused on pioneering treatments for autoimmune and...
Streetwise Reports | February 19, 2020 |

Exicure's Collaboration with Allergan on Treating Hair Loss Disorders Sends Shares Higher

Shares of Exicure Inc. opened 30% higher today after the firm reported that it entered into a collaboration agreement with Allergan to discover and develop SNA-based treatments for hair loss disorders. The terms of the deal provide for a $25 million upfront payment to Exicure ...
Streetwise Reports | November 15, 2019 |

VIDEO: FSD Pharma CEO Raza Bokhari updates investors on ‘HUGE’ news

FSD Pharma Inc. ( CSE: HUGE , OTCQB: FSDDF , Forum ) is focused on the research and development of novel cannabinoid-based treatments for several central nervous system disorders including chronic pain, fibromyalgia and irritable bowel syndrome, and on the deve...
Stockhouse Media | October 23, 2019 |
1 2 3 4 5 6 7 8 9 10 ...